정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2270 | Recruiting | ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects | COVID-19 Disease | Biological: ABNCoV2 | Phase 2 | Bavarian Nordic | INDUSTRY | 210 | All | 18 Years | Emovis GmbH, Berlin, Germany Clinical Research Hamburg GmbH, Hamburg, Germany |
| 2269 | Terminated | ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19 | COVID-19 | Drug: ABX464 Drug: Placebo |
Phase 3 | Abivax S.A. | INDUSTRY | 509 | All | 18 Years | Centre hospitalier Saint Pierre, Brussels, Belgium Hopital Erasme, Brussels, Belgium UZ Gent, Gent, Belgium Fundacao de Medicina Tropical Doutor Heitor Vieira Dourado - Instituto de Pesquisa Clinica Carlos Borborema, Manaus, Amazonas, Brazil Centro Oncologico de Roraima - CECOR - NAP, Boa Vista, Roraima, Brazil Hospital das Clinicas da FMUSP, Sao Paulo, Sao Paulo, Brazil Instituto Nacional de Infectologia Evandro Chagas - FIOCRUZ Rio de Janeiro, Rio De Janeiro, Brazil Conjunto Hospitalar do Mandaqui, Sao Paulo, Brazil Hopital Nord, Amiens, France Centre Hospitalier Departemental de Vendee, La Roche-sur-Yon, France Centre Hospitalier Universitaire de Nice, Nice, France Hopital Saint-Antoine, Paris, France Universitatsmedizin Mannheim Ruprecht-Karls-Universitat Heid, Mannheim, Baden-Wurttemberg, Germany Universitatsklinikum Bonn, Bonn, Nordrhein-Westfalen, Germany Asklepios Klinik St. Georg, Hamburg, Germany Asklepios Klinik Altona, Hamburg, Germany Fondazione IRCCS Ca Granda - Ospedale Maggiore Policlinico - Infectious Diseases, Milano, Lombardia, Italy Ospedale San Paolo, Milano, Lombardia, Italy Ospedale Luigi Sacco, AO-PU, Milano, Lombardia, Italy Ospedale di Vittorio Veneto - Medecina generale, Vittorio Veneto, Treviso, Italy Ospedale A. Manzonidi Lecco - ASST Lecco, Lecco, Italy Ospedale Niguarda, Milano, Italy Consultorio medico, Merida, Yucatan, Mexico Centro de Prevencion y Rehabilitacion de Enfermedades Pulmon, Nuevo Leon, Mexico Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain H.G.U. Alicante, Alicante, Spain Hospital del Mar, Barcelona, Spain Hospital de La Princesa, Madrid, Spain Hospital Universitario Infanta Leonor, Madrid, Spain Royal Free Hospital, London, United Kingdom |
| 2268 | Terminated | Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19 | COVID-19 | Drug: Acalabrutinib | Phase 1 | Acerta Pharma BV, AstraZeneca | INDUSTRY | 9 | All | 18 Years ~ 100 Years | Research Site, Porto Alegre, Brazil Research Site, Ribeirao Preto, Brazil Research Site, Sao Paulo, Brazil Research Site, Sao Paulo, Brazil |
| 2267 | Completed | Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. | COVID-19 | Drug: Acalabrutinib | Phase 2 | AstraZeneca, Acerta Pharma BV | INDUSTRY | 177 | All | 18 Years ~ 130 Years | Research Site, Ciudad de Buenos Aires, Argentina Research Site, Ciudad de Buenos Aires, Argentina Research Site, Monte Grande, Argentina Research Site, Ramos Mejia, Argentina Research Site, Botucatu, Brazil Research Site, Brasillia, Brazil Research Site, Florianopolis, Brazil Research Site, Porto Alegre, Brazil Research Site, Porto Alegre, Brazil Research Site, Ribeirao Preto, Brazil Research Site, Salvador, Brazil Research Site, Sao Bernardo do Campo, Brazil Research Site, Sao Paulo, Brazil Research Site, Sao Paulo, Brazil Research Site, Sao Paulo, Brazil Research Site, Curico, Chile Research Site, Santiago, Chile Research Site, Talca, Chile Research Site, Villejuif Cedex, France Research Site, Frankfurt, Germany Research Site, Gauting, Germany Research Site, Koln, Germany Research Site, Bangalore, India Research Site, New Delhi, India Research Site, Milano, Italy Research Site, Roma, Italy Research Site, Shinjuku-ku, Japan Research Site, D.F, Mexico Research Site, Monterrey, Mexico Research Site, Mexico, Mexico Research Site, Lima, Peru Research Site, Lima, Peru Research Site, Lima, Peru Research Site, Warszawa, Poland Research Site, Warszawa, Poland Research Site, Moscow, Russian Federation Research Site, Moscow, Russian Federation Research Site, Moscow, Russian Federation Research Site, Moscow, Russian Federation Research Site, Murmansk, Russian Federation Research Site, Cape Town, South Africa Research Site, George, South Africa Research Site, Johannesburg, South Africa Research Site, Johannesburg, South Africa Research Site, Pretoria, South Africa Research Site, Ankara, Turkey Research Site, Bakirkoy, Turkey Research Site, Istanbul, Turkey Research Site, Istanbul, Turkey Research Site, Umraniye, Turkey |
| 2266 | Completed | Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. | COVID-19 | Drug: Acalabrutinib | Phase 2 | AstraZeneca, Acerta Pharma BV | INDUSTRY | 62 | All | 18 Years ~ 130 Years | Research Site, Anniston, Alabama, United States Research Site, Mobile, Alabama, United States Research Site, Escondido, California, United States Research Site, Fullerton, California, United States Research Site, Glendale, California, United States Research Site, Newport Beach, California, United States Research Site, New Haven, Connecticut, United States Research Site, Washington, District of Columbia, United States Research Site, Fort Lauderdale, Florida, United States Research Site, Jacksonville, Florida, United States Research Site, Jacksonville, Florida, United States Research Site, Loxahatchee Groves, Florida, United States Research Site, Fort Wayne, Indiana, United States Research Site, Louisville, Kentucky, United States Research Site, Annapolis, Maryland, United States Research Site, Baltimore, Maryland, United States Research Site, Bethesda, Maryland, United States Research Site, Bethesda, Maryland, United States Research Site, Silver Spring, Maryland, United States Research Site, Hackensack, New Jersey, United States Research Site, Albany, New York, United States Research Site, Bronx, New York, United States Research Site, Buffalo, New York, United States Research Site, New York, New York, United States Research Site, Philadelphia, Pennsylvania, United States Research Site, Nashville, Tennessee, United States Research Site, Houston, Texas, United States Research Site, Houston, Texas, United States Research Site, Tyler, Texas, United States Research Site, Richmond, Virginia, United States Research Site, Renton, Washington, United States |
| 2265 | Recruiting | Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE | Covid19 | Drug: theraputic heparin Drug: prophylactic heparin Drug: P2Y12 Drug: Crizanlizumab Injection Drug: SGLT2 inhibitor |
Phase 4 | Matthew Neal MD, National Heart, Lung, and Blood Institute (NHLBI) | OTHER | 3000 | All | 18 Years | University of Alabama, Birmingham, Alabama, United States University of Arizona, Tucson, Arizona, United States University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States Kaiser Permanente Fontana, Fontana, California, United States Kaiser Permanente Los Angeles, Los Angeles, California, United States Smidt Heart Institute at Cedars-Sinai, Los Angeles, California, United States Ronald Reagan UCLA Medical Center, Los Angeles, California, United States UC San Diego Hillcrest, San Diego, California, United States Zuckerberg San Francisco General Hospital, San Francisco, California, United States UCSF San Francisco, San Francisco, California, United States Zuckerberg San Francisco General Hospital, San Francisco, California, United States Stanford University Medical Center, Stanford, California, United States Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States Denver Health and Hospital Authority, Denver, Colorado, United States St. Mary's Hospital & Regional Medical Center, Grand Junction, Colorado, United States Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States University of Florida, Gainesville, Florida, United States Memorial Hospital, Jacksonville, Florida, United States AdventHealth Tampa, Tampa, Florida, United States Emory, Atlanta, Georgia, United States Morehouse School of Medicine, Atlanta, Georgia, United States Queens Medical Center, Honolulu, Hawaii, United States Memorial Hospital, Belleville, Illinois, United States Cook County Health, Chicago, Illinois, United States University of Illinois at Chicago Health (UIH), Chicago, Illinois, United States OSF Little Company of Mary Medical Center (OSF LCM), Evergreen Park, Illinois, United States Indiana University Health Methodist Hospital, Indianapolis, Iowa, United States Kansas University Medical Center, Kansas City, Kansas, United States Ochsner Clinic Foundation, New Orleans, Louisiana, United States Boston University, Boston, Massachusetts, United States St Elizabeth's Medical Center, Brighton, Massachusetts, United States Baystate Medical Center, Springfield, Massachusetts, United States University of Massachusetts, Worcester, Massachusetts, United States University of Michigan, Ann Arbor, Michigan, United States Wayne State University, Detroit, Michigan, United States Hennepin County Medical Center, Minneapolis, Minnesota, United States University of Mississippi Medical Center, Jackson, Mississippi, United States Washington University School of Medicine, ACCS Research, Saint Louis, Missouri, United States University Medical Center of Southern Nevada, Las Vegas, Nevada, United States Cooper Health, Camden, New Jersey, United States Englewood Health, Englewood, New Jersey, United States Atlantic Health System, Morristown, New Jersey, United States Rutgers New Jersey Medical School, Newark, New Jersey, United States AtlantiCare Regional Medical Center, Pomona, New Jersey, United States Albany Medical College, Albany, New York, United States Jacobi Medical Center, Bronx, New York, United States Montefiore Medical Center, Bronx, New York, United States Mercy Hospital Buffalo, Buffalo, New York, United States VA New York Harbor Healthcare System, New York, New York, United States NYU Langone, New York, New York, United States Mt. Sinai Hospital, New York, New York, United States SUNY Upstate University Hospital, Syracuse, New York, United States Westchester Medical Center, Valhalla, New York, United States Duke University Hospital, Durham, North Carolina, United States Wake Forest, Winston-Salem, North Carolina, United States Cleveland Clinic Akron General, Akron, Ohio, United States University of Cincinnati Medical Center, Cincinnati, Ohio, United States The MetroHealth System, Cleveland, Ohio, United States Cleveland Clinic Foundation, Cleveland, Ohio, United States Ohio State Universtiy Wexner Medical Center, Columbus, Ohio, United States Mercy Health St Vincent Medical Center, Toledo, Ohio, United States Ascension St. John Clinical Research Institute, Tulsa, Oklahoma, United States Oregon Health and Science University, Portland, Oregon, United States Geisinger Research, Danville, Pennsylvania, United States Doylestown Cardiology Associates, Doylestown, Pennsylvania, United States Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States Temple University, Philadelphia, Pennsylvania, United States UPMC Presbyterian, Pittsburgh, Pennsylvania, United States Rhode Island Hospital, Providence, Rhode Island, United States The Miriam Hospital, Providence, Rhode Island, United States Sarah Cannon and HCA Research Institute, Nashville, Tennessee, United States Skyline Medical Center, Nashville, Tennessee, United States University of Texas at Austin, Austin, Texas, United States University of Texas Southwestern Medical Center, Dallas, Texas, United States Medical City Ft Worth, Fort Worth, Texas, United States Baylor Scott and White Medical Center - Temple, Temple, Texas, United States HCA Henrico Doctors Hospital, Richmond, Virginia, United States Swedish Hospital, Seattle, Washington, United States West Virginia University CTR, Morgantown, West Virginia, United States University of Wisconsin Hospital; Meriter Hospital (UW affiliated), Madison, Wisconsin, United States Hospital Universitario Sao Francisco de Assis, Braganca Paulista, Brazil Uniao Brasileira de Educacao e Assistencia - Hospital Sao Lucas da PUCRS, Porto Alegre, Brazil Centro de Estudos Clinicos do Hospital Cardio Pulmonar, Salvador, Brazil Fundacao Faculdade Regional De Medicina De Sao Jose Do Rio Preto, Sao Jose do Rio Preto, Brazil Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil Instituto do Coracao do Hospital das Clinicas da Faculdade de Medicina da USP-InCor-HCFMUSP, Sao Paulo, Brazil Azienda Ospedaliero Sant Anna e San Sebastiano, Caserta, Italy Maria Cecilia Hospital , Cotignola, Ravenna, Cotignola, Italy Universita degli Studi di Ferrara, Ferrara, Ferrara, Italy Azienda Ospedaliero -Universitaria Careggi, Firenze, Italy Policlinico di Napoli, Napoli, Napoli, Italy AOU Policlinico di Palermo, Palermo, Palermo, Italy ASL-1 Imperiese, Sanremo, Sanremo, Italy Hospital Universitario A Coruna, A Coruna, Spain Hospital Virgen del Mar, Almeria, Spain Hospital Arnau de Vilanova, Lleida, Spain Hospital Universitario La Paz, Madrid, Spain Hospital Universitario Ramon Y Cajal, Madrid, Spain Hospital Universitario Ramon Y Cajal, Madrid, Spain Hospital Clinico Universitario de Salamanca, Salamanca, Spain Hospital Clinico Universitario de Santiago de Compostela, Santiago de Compostela, Spain |
| 2264 | Terminated | ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic | History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection | Drug: 1: discontinuation of RAS blocker therapy Drug: 2: continuation of RAS blocker therapy |
Phase 3 | Assistance Publique - Hopitaux de Paris, Groupe Hospitalier Pitie-Salpetriere | OTHER | 44 | All | 18 Years | Cardiologie, Groupe Hospitalier Pitie-Salpetriere, Paris, France |
